Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 4
2006 2
2007 1
2008 1
2009 1
2013 1
2014 3
2015 2
2016 3
2017 1
2019 1
2020 6
2021 6
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Bergamini M, Dalla Volta A, Palumbo C, Zamboni S, Triggiani L, Zamparini M, Laganà M, Rinaudo L, Di Meo N, Caramella I, Bresciani R, Valcamonico F, Borghetti P, Guerini A, Farina D, Antonelli A, Simeone C, Mazziotti G, Berruti A. Bergamini M, et al. Among authors: valcamonico f. Elife. 2024 Apr 24;13:e92655. doi: 10.7554/eLife.92655. Elife. 2024. PMID: 38656229 Free PMC article. Clinical Trial.
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis.
Bergamini M, Dalla Volta A, Valcamonico F, Caramella I, Buffoni M, Munari E, Fisogni S, Zanotelli T, Suardi NR, Berruti A. Bergamini M, et al. Among authors: valcamonico f. Case Rep Oncol. 2024 Jan 5;17(1):56-68. doi: 10.1159/000535460. eCollection 2024 Jan-Dec. Case Rep Oncol. 2024. PMID: 38188482 Free PMC article.
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients.
Dalla Volta A, Caramella I, Di Mauro P, Bergamini M, Cosentini D, Valcamonico F, Cappelli C, Laganà M, Di Meo N, Farina D, Pedersini R, Mazziotti G, Berruti A. Dalla Volta A, et al. Among authors: valcamonico f. Curr Oncol Rep. 2023 Oct;25(10):1141-1152. doi: 10.1007/s11912-023-01447-9. Epub 2023 Aug 25. Curr Oncol Rep. 2023. PMID: 37624550 Free PMC article. Review.
Effect of Degarelix Administration on Bone Health in Prostate Cancer Patients Without Bone Metastases. The Blade Study.
Palumbo C, Dalla Volta A, Zamboni S, Mazziotti G, Zamparini M, Triggiani L, Borghetti P, Maffezzoni F, Bresciani R, Rinaudo L, Valcamonico F, Farina D, Magrini SM, Antonelli A, Simeone C, Berruti A. Palumbo C, et al. Among authors: valcamonico f. J Clin Endocrinol Metab. 2022 Nov 25;107(12):3398-3407. doi: 10.1210/clinem/dgac489. J Clin Endocrinol Metab. 2022. PMID: 35971857
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients?
Caramella I, Dalla Volta A, Valcamonico F, Grisanti S, Berruti A. Caramella I, et al. Among authors: valcamonico f. Prostate Cancer Prostatic Dis. 2022 Apr;25(4):797. doi: 10.1038/s41391-021-00474-6. Epub 2021 Nov 22. Prostate Cancer Prostatic Dis. 2022. PMID: 34811500 No abstract available.
Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network.
Bianchi S, Mosca A, Dalla Volta A, Prati V, Ortega C, Buttigliero C, Fea E, Vanella P, Valcamonico F, Zamparini M, Sirotova Z, Chiappino I, Dal Canton O, Masini C, Sacco C, Amoroso D, Montagnani F, Comandone A, Bellissimo AR, Ciccone G, Baier S, Gennari A, Tucci M, Berruti A. Bianchi S, et al. Among authors: valcamonico f. Eur J Cancer. 2021 Sep;155:127-135. doi: 10.1016/j.ejca.2021.06.034. Epub 2021 Aug 6. Eur J Cancer. 2021. PMID: 34371442 Clinical Trial.
36 results